Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 8:45 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1609–1632 of 1,870 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: BE-FAST Clear all

Conditions: End-Stage Renal Disease
Interventions: Daclizumab, Methylprednisolone/prednisone, Mycophenolate mofetil, Sirolimus, Bactrim, Ganciclovir, Lipitor; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: Up to 21 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2006
U.S. locations: 1
States / cities: Rockville, Maryland

Conditions: Obstructive Sleep Apnea Syndrome
Interventions: Sleep Study, Neurocognitive Testing, CBF During Wakefulness, CBF During Sleep; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 6 Years to 12 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pulmonary Aspiration
Interventions: GLP-1 RA users with prolonged fasting instructions, GLP-1 RA users with standard NPO instructions; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Congenital Cystic Kidney Disease
Interventions: Venglustat GZ402671; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Opioid Use, Opioid-use Disorder, Substance Use Disorders
Interventions: Sky Intervention; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Cystic Fibrosis Related Diabetes, Pancreatic Insufficiency
Interventions: placebo, repaglinide; Drug
Lead sponsor: Arbelaez, Ana Maria; Individual
Eligibility: 12 Years to 24 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Low Back Pain
Interventions: Spinal treatment, Massage; Procedure
Lead sponsor: Palmer College of Chiropractic; Other
Eligibility: 21 Years to 65 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Davenport, Iowa

Conditions: Prediabetes, Type 2 Diabetes
Interventions: Metformin, Glargine; Drug
Lead sponsor: RISE Study Group; Network
Eligibility: 10 Years to 19 Years
Enrollment: 91 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 4
States / cities: Denver, Colorado • New Haven, Connecticut • Indianapolis, Indiana + 1 more

Conditions: Acute Myocardial Infarction
Interventions: Not listed
Lead sponsor: Hennepin County Medical Center, Minneapolis; Other
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Amputation
Interventions: Multiaxial Prosthetic Foot Emulator, Commercially available prosthetic feet; Device
Lead sponsor: Seattle Institute for Biomedical and Clinical Research; Other
Eligibility: 18 Years to 89 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Seattle, Washington

Conditions: Prediabetes
Interventions: Hourly 3-Minute Light Walking Breaks, Hourly Stair-Climbing Exercise Snacks; Behavioral
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 69 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Type2 Diabetes Mellitus, Cardiovascular Diseases
Interventions: Early Total Caloric Intake, Late Total Caloric Intake, Extended Overnight Fast; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 30 Years to 75 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Pregnancy, Labor Pain
Interventions: Routine oxytocin, Half-dose oxytocin; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 172 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Multiple Sclerosis, RRMS, Relapsing Remitting MS
Interventions: HP 13C pyruvate injection, MRI Scanner; Drug · Device
Lead sponsor: Ari Green; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cancer
Interventions: Continuing Medical Education Events (CME), Trial Connect Portal, Clinical Trial Newsletters, Implicit Bias Training, Recruitment Dashboard, Portfolio Profiler, Eligibility Calculator, Clinical Trial Education Sessions (Community Residents Only), ACT WONDER²S Phone-line/Email (Community Residents and Moffitt Patients), New Patient Information (Moffitt Patients Only), No Intervention; Behavioral · Other
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 7,649 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Glioblastoma Multiforme, Anaplastic Glioma
Interventions: Temodar and O6-Benzylguanine (BG); Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pancreatitis, Diabetes Mellitus
Interventions: Research MRI without administration of intravenous secretin, Research MRI with administration of intravenous secretin, Genetic Sequencing, Blood Tests, Stool Tests, Survey Completion, Endoscopic pancreatic function tests (ePFTs), Secretin; Diagnostic Test · Genetic · Other + 1 more
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 5 Years to 21 Years
Enrollment: 195 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Obesity
Interventions: 24-hour energy expenditure; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 50 Years to 65 Years · Female only
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Kannapolis, North Carolina

Conditions: Renal Impairment, Healthy Participants
Interventions: Linzagolix; Drug
Lead sponsor: ObsEva SA; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Orlando, Florida • Saint Paul, Minnesota

Conditions: Intubation
Interventions: Biphasic Cuirass Ventilation; Device
Lead sponsor: University Medical Center of Southern Nevada; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Pediatric Low-grade Gliomas
Interventions: Wave-CAIPI; Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 0 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2028
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: Bone Marrow Transplantation
Interventions: Fecal Microbiota Transplantation (FMT); Biological
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pyelonephritis, Pyelonephritis Acute, Renal Sclerosis
Interventions: Quick MRI; Diagnostic Test
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 0 Years to 21 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Melanoma
Interventions: fludeoxyglucose F 18, Positron emission tomography-computed tomography, 18F-fluorothymidine, Positron emission tomography-magnetic resonance imaging; Drug · Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

Pediatric Kidney Transplant Without Calcineurin Inhibitors

Cerebral Blood Flow and Childhood Obstructive Sleep Apnea

Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor (GLP-1 RA) Agonist Prior to Anesthesia

Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat

Evaluating The Efficacy Of A Mind-Body Intervention In Overcoming Opioid Addiction

Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis

PRoGReSS-PS: Patient Response to GRraded Sensory Stimulation: A Pilot Study

RISE Pediatric Medication Study

Paced Electrocardiogram Requiring Fast Emergent Coronary Therapy (PERFECT) Study

A Prosthetic Foot Test-Drive Strategy for Improving Stability in Veterans With Leg Amputations

Effects of Hourly Stair-Climbing Exercise Snacks on Metabolic and Vascular Health in Adults With Prediabetes

Behavioral Chronotype: Impact on Sleep and Metabolism

Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes

Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis

Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)

Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma

Imaging Biomarkers of Pancreatic Function and Disease

Energy Expenditure and Substrate Utilization During Acute Under- and Over-feeding

Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function

Biphasic Ventilation Airway Management Clinical Trial

Developing Fast Pediatric Imaging

Fecal Microbiota Transplantation After HSCT

The Validity of the Quick Renal MRI in Pediatric Kidney Disease

18F-FLT PET Imaging in Patients With Advanced Melanoma